M42’s Imperial College London Diabetes & Endocrine Centre and HealthPlus Diabetes and Endocrinology Center Drive One of the UAE’s Largest Diabetes Awareness Campaigns, Engaging Nearly 4,000 People

18 community, corporate, and government engagements delivered across Abu Dhabi, Al Ain, and Al Dhafra

  • M42’s ICLDEC & HealthPlus Diabetes and Endocrinology Center engaged a record-number of people across Abu Dhabi, Al Ain and Al Dhafra
  • 18 major community, corporate and government activations delivered early detection
  • Free health screenings and expert sessions reached frontline organisations including Mubadala, Aldar, Daman, Modon, HCT, Central Bank of the UAE and Abu Dhabi Police
  • 1,000+ healthcare professionals attended the 3rd Annual Diabetes and Endocrine Conference, strengthening regional clinical expertise
  • 600+ people joined the Diabetes Awareness Run at Zayed Sports Stadium, driving momentum for active living
  • 13 children living with diabetes had wishes granted through Make-A-Wish collaboration

Abu Dhabi, U.A.E., December 08, 2025: Diabetes Awareness Month took on new meaning across the emirate this year, as nearly 4,000 people engaged with M42’s Imperial College London Diabetes & Endocrine Centre (ICLDEC) and HealthPlus Diabetes & Endocrinology Center through one of the UAE’s most comprehensive, community-driven diabetes initiatives to date.

Across Abu Dhabi, Al Ain, and Al Dhafra, specialist teams from ICLDEC, Moorfields, and HealthPlus Diabetes & Endocrinology Center activated a month-long campaign that brought early detection, specialist education, and meaningful community support directly into workplaces, schools, majlis gatherings, and public spaces. The initiative reached leading corporates such as Mubadala, Aldar, Daman, the Higher Colleges of Technology, Central Bank of the UAE and Abu Dhabi Police.

Through free screenings, expert-led awareness sessions, medical conferences, community events, and family-focused activities, the initiative created impactful moments of engagement, helping individuals understand their risk, supporting people living with diabetes, and empowering families to take control of their health.

The campaign not only raised awareness but also mobilised communities at scale, reinforcing the critical role of prevention, education, and early intervention in reducing the national diabetes burden.

The initiative extended beyond health checks. It sparked conversations, strengthened community bonds, and delivered joy through special activations such as a Make-A-Wish collaborations for paediatric patients, transforming a clinical topic into a movement centered on compassion, prevention, and community wellbeing.

By integrating clinical expertise with community-driven outreach, the programme showcased M42’s commitment to reshaping the future of personalised, proactive, and preventive health across the UAE.

Dr. Mai Ahmed Al Jaber, CEO of Outpatient Care, M42, said: “Diabetes Awareness Month provides an important opportunity for us to engage directly with communities, raise awareness around early detection, and support healthier living. By delivering comprehensive screenings, educational activations, and public events, we are helping individuals better understand their health and empowering families across the emirate to take proactive steps in diabetes prevention and management.”

Reinforcing their commitment to advancing clinical knowledge, the centres also supported major regional medical events throughout the month. The 3rd Annual Diabetes & Endocrine Conference welcomed more than 1,000 attendees over two days, facilitating scientific exchange and professional learning. ICLDEC physicians chaired and participated in the 7th UAE Obesity Conference, contributing to broader discussions on obesity and metabolic health in the region.

Community engagement remained a central pillar of the month’s initiatives. On 23 November, ICLDEC and HealthPlus Diabetes & Endocrinology Center, in partnership with Abu Dhabi Public Health Center (ADPHC), hosted the Diabetes Awareness Run at Zayed Sports Stadium in Abu Dhabi, attracting more than 600 participants to promote active living and raise awareness of diabetes prevention. Complementing these efforts, Family Fun Days were held in Abu Dhabi and Al Ain for staff and paediatric patients, featuring football, “bike your juice,” canvas painting, face painting, and other interactive activities designed to promote awareness in an engaging, family-friendly environment.

As part of Diabetes Awareness Day on 14 November, the centres partnered with the Make-A-Wish Foundation to grant wishes for 13 pediatric patients living with diabetes. The initiative added a deeply personal dimension to the month’s activities, bringing joy and meaningful support to young patients and their families.

Dr. Muhaned Attaulah, Senior Director of Clinical Operations, Outpatient Care, M42, said: “Our work throughout Diabetes Awareness Month reflects our broader mission to support individuals and families affected by diabetes. From clinical outreach to community events and collaborations with partners such as Make-A-Wish, every initiative is part of our ongoing commitment to improving lives and reducing the impact of diabetes across the UAE.”

The collective impact of the month-long campaign positions M42’s ICLDEC and HealthPlus Diabetes & Endocrinology Center as leading drivers of national diabetes awareness, prevention, and long-term health transformation.

– ENDS –

About the Imperial College London Diabetes & Endocrine Centre

Imperial College London Diabetes & Endocrine Centre (ICLDEC), an M42 company, is a state-of-the-art outpatient facility that specialises in treatment, research, training, and public health awareness for diabetes and endocrine-related health conditions. Over the last two decades, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.

With more than 70 diabetes professionals and endocrinologists under one roof, Imperial College London Diabetes & Endocrine Centre offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre- and post-bariatric surgery care, heart disease prevention, nutritional advice, diabetes education services, ophthalmology, nephrology, and podiatry.

ICLDEC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates four branches across Abu Dhabi, Al Dhafra and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives. In 2007, ICLDEC launched Diabetes. Knowledge. Action, now the longest running public health awareness campaign in the country. The initiative promotes an active lifestyle through an ongoing calendar of events for the whole community.

ICLDEC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.

For more information, please visit www.icldec.ae

About HealthPlus Diabetes & Endocrinology Center

Part of HealthPlus Network of Specialty Centers, the HealthPlus Diabetes & Endocrinology Center, part of M42, has established itself as a Center of Excellence in Diabetes Care through its multi-disciplinary approach to diabetes management and treatment. With a focus on patient care, clinical outcomes, education and training, HealthPlus Diabetes & Endocrinology Center philosophy is at the forefront of the latest medical advances, providing the best available evidence-based diabetes and endocrine treatments consistently and effectively to its patients. The center’s specialties include Diabetology, Endocrinology, Ophthalmology, Cardiology, Internal Medicine, Podiatry, Psychiatry, Nutrition, Dermatology and more.

About M42

M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.

Established in 2023, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.